跳至主要内容
临床试验/ISRCTN65171867
ISRCTN65171867已完成不适用

Multicentric, randomized, comparative, open-labeled trial of a fixed dose combination of cefepime and amikacin versus cefepime alone in nosocomial pneumonia

Venus Remedies Limited (India)0 个研究点目标入组 200 人开始时间: 2006年6月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Participants included were 200 patients infected with nosocomial pneumonia showing presence of pus cells more than 25 high power fields (HPF) and buccal epithelial cells less than 10 HPF

排除标准

  • 1. Hypersensitivity to cefepime, amikacin or related drugs
  • 2. Children or adolescents less than 18 years of age
  • 3. Pregnant women
  • 4. Patients with renal or hepatic insufficiency
  • 5. Patients not willing to give written informed consent

研究者

发起方
Venus Remedies Limited (India)

相似试验